Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 4/20 | 0.48 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.37 |
| ▸ | LSS | P48449 | 2/20 | 0.37 |
| ▸ | PKM | P14618 | 1/20 | 0.37 |
| ▸ | SIGMAR1 | Q99720 | 3/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | THRB | P10828 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4923265 | 1.00 | CYP1A2 (0.48) | CYP1A2EPHX1ALDH1A1HTTMEN1 | |
| SCHEMBL4921924 | 1.00 | CYP1A2 (0.48) | CYP1A2EPHX1ALDH1A1HTTMEN1 | |
| SCHEMBL27618641 | 1.00 | CYP1A2 (0.48) | CYP1A2EPHX1ALDH1A1HTTMEN1 | |
| SCHEMBL55638 | 1.00 | CYP1A2 (0.48) | CYP1A2EPHX1ALDH1A1HTTMEN1 | |
| SCHEMBL4921810 | 1.00 | CYP1A2 (0.48) | CYP1A2EPHX1ALDH1A1HTTMEN1 | |
| SCHEMBL8744097 | 1.00 | CYP1A2 (0.48) | CYP1A2EPHX1ALDH1A1HTTMEN1 | |
| SCHEMBL1127668 | 1.00 | CYP1A2 (0.48) | CYP1A2EPHX1ALDH1A1HTTMEN1 | |
| SCHEMBL27449477 | 0.98 | CYP1A2 (0.46) | CYP1A2EPHX1ALDH1A1HTTMEN1 | |
| SCHEMBL548259 | 0.98 | CYP1A2 (0.50) | CYP1A2EPHX1ALDH1A1HTTMEN1 | |
| SCHEMBL455412 | 0.92 | CYP1A2 (0.52) | CYP1A2EPHX1ALDH1A1HTTMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 137 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0194525-B1 | N-CARBAMOYL-AZOLES AND FUNGICIDES CONTAINING THEM | BASF Aktiengesellschaft (DE) | 1988-08-10 | — | — | EP | claimed |
| WO-2023189353-A1 | TREATMENT LIQUID, TREATMENT METHOD, AND METHOD FOR MANUFACTURING ELECTRONIC DEVICE | 富士フイルム株式会社 | 2023-10-05 | — | — | WO | disclosed |
| EP-4023640-A1 | PHENYLIMIDAZOLE COMPOUND | Otsuka Pharmaceutical Factory, Inc. (JP) | 2022-07-06 | — | — | EP | disclosed |
| CN-113200962-A | Phenylimidazole compounds | 株式会社大塚制药工场 | 2021-08-03 | — | — | CN | disclosed |
| CN-108430977-B | Phenylimidazole compounds | 株式会社大塚制药工场 | 2021-06-08 | — | — | CN | disclosed |
| CN-112521774-A | Isoindoline pigment and method for producing same | 住友化学株式会社 | 2021-03-19 | — | — | CN | disclosed |
| CN-108008600-B | Radiation-sensitive composition | 三菱瓦斯化学株式会社 | 2021-02-09 | — | — | CN | disclosed |
| EP-2080750-B1 | RADIATION-SENSITIVE COMPOSITION | MITSUBISHI GAS CHEMICAL CO (JP) | 2020-07-29 | — | — | EP | disclosed |
| US-10570117-B2 | Phenylimidazole compound | OTSUKA PHARMACEUTICAL FACTORY, INC. (JP) | 2020-02-25 | — | — | US | disclosed |
| US-20180354930-A1 | PHENYLIMIDAZOLE COMPOUND | OTSUKA PHARMACEUTICAL FACTORY, INC. (JP) | 2018-12-13 | — | — | US | disclosed |
| EP-0129582-A1 | ORALLY ADMINISTERED BIOLOGICALLY ACTIVE PEPTIDES AND PROTEINS | University of Washington (US) | 1985-01-02 | — | — | EP | disclosed |
| EP-0120717-A2 | Anthraquinone dyes and liquid crystal compositions containing the dyes | MITSUBISHI KASEI CORPORATION (JP) | 1984-10-03 | — | — | EP | disclosed |
| EP-0120463-A2 | Anthraquinone dyes and liquid crystal compositions including the same | HITACHI, LTD. (JP) | 1984-10-03 | — | — | EP | disclosed |
| US-4459218-A | Composition for liquid crystal color display | MITSUI TOATSU CHEMICALS, INC. (JP) | 1984-07-10 | — | — | US | disclosed |
| WO-1984002467-A1 | ORALLY ADMINISTERED BIOLOGICALLY ACTIVE PEPTIDES AND PROTEINS | RESEARCH CORP (US) | 1984-07-05 | — | — | WO | disclosed |
| US-4434072-A | PLEOCHROIC ANTHRAQUINONE DYE | MITSUBISHI CHEMICAL INDUSTRIES, LTD. (JP) | 1984-02-28 | — | — | US | disclosed |
| EP-0098736-A2 | Anthraquinone dyes and liquid crystal compositions containing the dyes | MITSUBISHI KASEI CORPORATION (JP) | 1984-01-18 | — | — | EP | disclosed |
| EP-0085404-A1 | Stabilized linear low density polyethylene | BORG-WARNER CHEMICALS INC. (US) | 1983-08-10 | — | — | EP | disclosed |
| EP-0060895-A1 | COMPOSITION FOR LIQUID CRYSTAL COLOR DISPLAY | MITSUI TOATSU CHEMICALS, Inc. (JP) | 1982-09-29 | — | — | EP | disclosed |
| US-3935015-A | Silver halide color photographic materials containing 3-anilino-5-pyrazolane couplers | FUJI PHOTO FILM CO., LTD. (JA) | 1976-01-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10570117-B2 | Phenylimidazole compound | LPL, PNLIP, LIPC | CYP1A2 140/4885EPHX1 2135/4885ALDH1A1 263/4885 |
| US-20180354930-A1 | PHENYLIMIDAZOLE COMPOUND | PNLIP, PLIN1, HDAC11 | CYP1A2 1421/4885EPHX1 3696/4885ALDH1A1 457/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.